CA2219758A1 - Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders - Google Patents

Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders Download PDF

Info

Publication number
CA2219758A1
CA2219758A1 CA002219758A CA2219758A CA2219758A1 CA 2219758 A1 CA2219758 A1 CA 2219758A1 CA 002219758 A CA002219758 A CA 002219758A CA 2219758 A CA2219758 A CA 2219758A CA 2219758 A1 CA2219758 A1 CA 2219758A1
Authority
CA
Canada
Prior art keywords
bismuth
milligrams
antimicrobials
days
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002219758A
Other languages
English (en)
French (fr)
Inventor
Jamesina Anne Fitzgerald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2219758A1 publication Critical patent/CA2219758A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002219758A 1995-05-09 1996-05-08 Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders Abandoned CA2219758A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US437,475 1989-11-16
US43747595A 1995-05-09 1995-05-09

Publications (1)

Publication Number Publication Date
CA2219758A1 true CA2219758A1 (en) 1996-11-14

Family

ID=23736610

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002219758A Abandoned CA2219758A1 (en) 1995-05-09 1996-05-08 Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders

Country Status (6)

Country Link
EP (1) EP0830135A1 (de)
JP (1) JPH11504940A (de)
AU (1) AU5733696A (de)
CA (1) CA2219758A1 (de)
PE (1) PE48297A1 (de)
WO (1) WO1996035436A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2791888B1 (fr) * 1999-04-06 2004-10-08 Ethypharm Lab Prod Ethiques Suspension pharmaceutique buvable
BR0009557A (pt) 1999-04-06 2002-05-28 Ethypharm Lab Prod Ethiques Suspensão farmacêutica para beber de ibuprofeno
KR20190026962A (ko) 2014-09-05 2019-03-13 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU590578B2 (en) * 1985-04-18 1989-11-09 Procter & Gamble Company, The Treatment of non-ulcer dyspepsia with bismuth salts
ATE318144T1 (de) * 1985-06-13 2006-03-15 Barry James Marshall Pharmazeutische zusammensetzung zur behandlung gastrointestinaler beschwerden, die wismut und ein antimikrobielles mittel enthält
JP2733849B2 (ja) * 1987-10-12 1998-03-30 ボロディー，ソーマス・ユリウス 胃腸障害治療のための改良された方法
EP0624373B1 (de) * 1993-05-11 1999-09-08 Spirig Ag Pharmazeutische Präparate Festes bismut- und amoxycillinhaltiges Arzneipräparat und seine Verwendung

Also Published As

Publication number Publication date
AU5733696A (en) 1996-11-29
WO1996035436A1 (en) 1996-11-14
PE48297A1 (es) 1998-02-04
EP0830135A1 (de) 1998-03-25
JPH11504940A (ja) 1999-05-11

Similar Documents

Publication Publication Date Title
US5256684A (en) Methods and compositions for the treatment of gastrointestinal disorders
CA1277232C (en) Methods and compositions for the treatment of gastrointestinal disorders
JP2733849B2 (ja) 胃腸障害治療のための改良された方法
Van Nieuwenhove et al. Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-α-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial
Castro et al. Altered small bowel propulsion associated with parasitism
JP2648327B2 (ja) 胃腸疾患を治療するための組成物及び方法
KR970007188B1 (ko) 위장장해 치료 조성물
World Health Organization The rational use of drugs in the management of acute diarrhoea in children
AU590578B2 (en) Treatment of non-ulcer dyspepsia with bismuth salts
CZ286202B6 (cs) Farmaceutický přípravek
EP1189622B1 (de) Anionische polymer als toxinbindemittels und antibacterische mittel
McDermott et al. The absorption, excretion, and destruction of orally administered penicillin
RU2116071C1 (ru) Лекарственные препараты, набор и способ лечения желудочно-кишечных заболеваний, вызываемых или опосредуемых заражением helicobaeter pylori
CA2219758A1 (en) Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders
IE862800L (en) Use of nitrofurantion for a manufacture
US6051604A (en) Methods and compositions for the prevention and treatment of gastrointestinal disorders
Beaty et al. Iatrogenic factors in infectious disease
O'Callaghan et al. Vincristine toxicity unrelated to dose.
CA2239423C (en) Compositions, containing bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders
EP0830134A1 (de) Zusammensetzungen zur behandlung und vorbeugung von magen-darmstörungen welche wismut enthalten
Robinson et al. Severe diarrhea secondary to propranolol
Alestig et al. Studies on the absorption and excretion of minocycline and a comparison with doxycycline
CA2239422C (en) Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders
Johnson et al. Travelers’ diarrhea, new perspectives
Tolle et al. The evaluation and management of acute diarrhea.

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead